Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

Deals & Financings

VC fundings, mergers and acquisitions, and other financing events...

Structure Stages Expanded $161 Million IPO for Novel Small Molecules

AnHeart to Use Guardant’s Assays for NSCLC Trials of ROS1 Inhibitor

NeuShen and UMass Partner To Develop Gene Therapy for ALS

CS Pharma Acquires China Rights to Fibrosis Drug in $336 Million Agreement

HBMAT, a Harbour Biomed JV, Closes Seed Round for Novel Endocrine Therapies

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China